Executive Director, Emerging Therapeutic Areas

Position Summary

The Executive Director, Emerging Therapeutic Areas provides strategic US medical leadership for key pipeline oncology assets, delivering an integrated US voice into research and development plans to increase relevance and impact of pipeline assets for the US market.  Through cross-functional partnership, the role advocates for development and evidence strategies that align with future US treatment landscape and stakeholder expectations, helping to optimize clinical relevance and operational feasibility of oncology clinical trial programs.

The role leads the US Medical Oncology Emerging Therapeutic Areas team, integrating headquarters medical strategy with field medical execution to ensure robust bidirectional insight generation, support clinical trial site selection and enrollment, and build medical and evidence foundations required for successful transition of assets for commercialization. This role works with the US Oncology Therapeutic Head to ensure the US Medical Oncology Emerging Therapeutic Areas team has the appropriate expertise and resources in place to support new medicines coming to market. They will partner closely with Commercial Early Asset leads, Market Access, Global Medical Affairs, and R&D teams. 

Responsibilities
This role will provide YOU the opportunity to lead key activities to progress YOUR career. These responsibilities include some of the following:

• Direct and oversee the US Medical Oncology Emerging Therapeutic Areas team, establishing priorities, ensuring alignment, and driving high-quality scientific and strategic execution.

• Drive Medical Affairs activities to understand US unmet needs, healthcare delivery patterns, access dynamics, and customer stakeholders in key tumor areas

• In partnership with Commercial and Market Access, develop integrated US point of view on unmet needs and commercial challenges and opportunities in priority tumor areas, including resourcing needs and potential go to market plans for future launches. 

• Shape Clinical trial protocol design, eligibility criteria, endpoints, comparator strategy, and study feasibility to increase US relevance and operational viability.

• Lead development and oversee execution of US Medical Plans for priority oncology pipeline assets, ensuring team activities align with asset strategy; Co-create (with Global Medical Affairs) integrated evidence generation plans, ensuring evidence strategies address future treatment decision-making and value demonstration needs.

•  Set strategic direction for Lung/GU/GI MSL engagement, ensuring the team generates meaningful insights, sustains strong external expert relationships, and identifies investigators and research-ready sites aligned with pipeline priorities.

• Develop and maintain a robust US external expert map, guiding team efforts to engage academic and community leaders, cooperative groups, and research networks to support pipeline strategy and scientific exchange.

• Establish medical and scientific foundations for future asset transitions, ensuring early scientific communication approaches, disease education considerations, and stakeholder engagement strategies are appropriately shaped.

Why You?

Work arrangement
This role is hybrid, based in the United States, and requires regular office presence plus travel as needed.

Basic Qualification
We are seeking professionals with the following required skills and qualifications to help us achieve our goals:

• PhD, PharmD, MD, or equivalent advanced health professional degree.

• 5 + years in Oncology Medical Affairs pharmaceutical industry roles, with at least 3 years in US-focused roles.

• Experience influencing clinical development strategy and protocol design for pipeline assets through medical insight and cross-functional collaboration.

Preferred Qualification
If you have the following characteristics, it would be a plus:

• Strong oncology expertise, with experience across multiple therapeutic areas such as lung, GU, GI, and GIST

• Experience leading US medical strategy for pipeline or early asset programs

• Experience leading or partnering with field medical organizations and leveraging field-generated insights to inform strategy

• Strong understanding of US oncology practice patterns, treatment landscapes, and healthcare system dynamics

• Experience in evidence planning, integrated evidence strategy, or collaboration with HEOR and Value & Access teams

• Demonstrated ability to lead cross-functional initiatives in a complex, matrixed environment

• Proven ability to build and sustain relationships with external oncology experts and investigators

• Strong leadership, communication, and strategic thinking skills, with experience managing medical teams

How to apply
If this role matches your experience and ambition, we welcome your application. Tell us how you will shape medical strategy, support patients and grow your career at GSK. We look forward to hearing from you.

#LI-GSK

Please visit  GSK US Benefits Summary to learn more about the comprehensive benefits program GSK offers US employees.

Why GSK?

Uniting science, technology and talent to get ahead of disease together.

GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases – to impact health at scale.

People and patients around the world count on the medicines and vaccines we make, so we’re committed to creating an environment where our people can thrive and focus on what matters most. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people.

Should you require any adjustments to our process to assist you in demonstrating your strengths and capabilities contact us at HR.AmericasSC-CS@gsk.com where you can also request a call.

Please note should your inquiry not relate to adjustments, we will not be able to support you through these channels. However, we have created a Recruitment FAQ guide. Click the link where you will find answers to multiple questions we receive

GSK is an Equal Opportunity Employer. This ensures that all qualified applicants will receive equal consideration for employment without regard to race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), parental status, national origin, age, disability, genetic information (including family medical history), military service or any basis prohibited under federal, state or local law.

Important notice to Employment businesses/ Agencies

GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.

Please note that if you are a US Licensed Healthcare Professional or Healthcare Professional as defined by the laws of the state issuing your license, GSK may be required to capture and report expenses GSK incurs, on your behalf, in the event you are afforded an interview for employment. This capture of applicable transfers of value is necessary to ensure GSK’s compliance to all federal and state US Transparency requirements. For more information, please visit the Centers for Medicare and Medicaid Services (CMS) website at https://openpaymentsdata.cms.gov/